Please wait while the formulary information is being retrieved.
ELOCTATE (antihemophilic factor (FVIII) recombinant, Fc fusion protein)
- Hemophilia A
- Bleeding episode in hemophilia A
- Bleeding prevention in hereditary factor VIII deficiency
1,000 unit intravenous solution
- Dosage information is not available
1,500 unit intravenous solution
- Dosage information is not available
2,000 unit intravenous solution
- Dosage information is not available
250 unit intravenous solution
- Dosage information is not available
3,000 unit intravenous solution
- Dosage information is not available
4,000 unit intravenous solution
- Dosage information is not available
5,000 unit intravenous solution
- Dosage information is not available
500 unit intravenous solution
- Dosage information is not available
6,000 unit intravenous solution
- Dosage information is not available
750 unit intravenous solution
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- No disease contraindications
ELOCTATE (antihemophilic factor (FVIII) recombinant, Fc fusion protein)
- Hemophilia A
- Bleeding episode in hemophilia A
- Bleeding prevention in hereditary factor VIII deficiency
- None
- Dizziness
- Fever
- Headache disorder
- Infection
- Nausea
- Pruritus of skin
More Frequent
Severe
Less Severe
- Allergic dermatitis
- Anaphylaxis
- Angioedema
- Dyspnea
- Erythema
- Fibrinogen excess
- Skin rash
- Thrombocytopenic disorder
- Thrombotic disorder
- Urticaria
- Wheezing
- Chest discomfort
- Chills
- Drowsy
- Dysgeusia
- Fatigue
- Flushing
- Injection site sequelae
- Lethargy
- Vomiting
- Xerostomia
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute myocardial infarction
- Cerebrovascular accident
- Chest tightness
- Disseminated intravascular coagulation
- Hemolytic anemia
- Hypersensitivity drug reaction
- Hypertension
- Pulmonary thromboembolism
- Thromboembolic disorder
- Viral infection
Less Severe
- Acute abdominal pain
- Cough
- Diarrhea
- Hypotension
- Paresthesia
- Tachycardia
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Antihemophilic Factor,recombinant
- Severity Level:
C
- Additional Notes: Insufficient data available
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Antihemophilic Factor,recombinant
Insufficient data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Bleeding episode in hemophilia A | |
| D66 | Hereditary factor VIII deficiency |
| Z14.02 | Symptomatic hemophilia A carrier |
| Bleeding prevention in hereditary factor VIII deficiency | |
| D66 | Hereditary factor VIII deficiency |
| Hemophilia A | |
| D66 | Hereditary factor VIII deficiency |
| Z14.02 | Symptomatic hemophilia A carrier |
| 0-9 | A-Z |
|---|---|
| D66 | Hereditary factor VIII deficiency |
| D66 | Hereditary factor VIII deficiency |
| D66 | Hereditary factor VIII deficiency |
| Z14.02 | Symptomatic hemophilia A carrier |
| Z14.02 | Symptomatic hemophilia A carrier |
Formulary Reference Tool